• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stepan Reports Third Quarter 2025 Results

    10/29/25 7:00:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $SCL alert in real time by email

    NORTHBROOK, Ill., Oct. 29, 2025 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported:

    Stepan Company Logo (PRNewsfoto/Stepan Company)

    Third Quarter 2025 Highlights

    • Reported net income was $10.8 million, down 54% versus the prior year. Adjusted net income(1) was $10.9 million, down 54% versus the prior year, largely due to a higher effective tax rate and higher interest expense.
    • EBITDA(2) was $56.1 million and Adjusted EBITDA(2) was $56.2 million, both up 6% respectively, year-over-year.
    • Global sales volume was up 1% year-over-year.
    • Cash from Operations was $69.8 million during the quarter. Free cash flow(3) for the quarter was $40.2 million, driven by a reduction in working capital.
    • Year-over-year pre-tax earnings were negatively impacted by $8.6 million due to higher costs associated with the start-up our new alkoxylation site in Pasadena, Texas and lower capitalized interest income recognition due to the Pasadena start-up.

    YTD 2025 Highlights

    • Reported net income was $41.9 million, down 11% versus the prior year. Adjusted net income(1) was $42.2 million, down 12% versus the prior year.
    • EBITDA(2)  was $164.7 million and Adjusted EBITDA(2) was $165.1 million, both up 9% respectively, year-over-year.
    • Global sales volume was up 2% year-over-year.

    "Third quarter adjusted EBITDA grew 6% and free cash flow improved to $40.2 million dollars for the quarter.  Year-to-date adjusted EBITDA is up 9% with volumes up 2%.  We achieved these positive results despite higher start-up expenses at our Pasadena site and a significant run up in oleochemical raw material costs," said Luis E. Rojo, President and Chief Executive Officer.  "Third quarter Adjusted Net Income was negatively impacted by a higher effective tax rate, higher depreciation and higher interest net versus prior year, none of which had a cash impact.  From a segment perspective, Polymer volume was up 8% as our Rigid, Specialty Polyols and Phthalic Anhydride businesses all delivered volume growth.  Within Surfactants, we experienced double digit volume growth within the Agricultural and Industrial Cleaning end markets and mid-single digit growth within the Oilfield end markets.  This growth was offset by lower demand in the global commodity Consumer Products end markets. Specialty Products delivered earnings growth during the quarter due to order timing differences. We are encouraged by volume growth across several key strategic end markets, and we remain focused on gradually restoring margins while maintaining a healthy balance between volume and margins."

    Financial Summary





    Three Months Ended

    September 30,





    Nine Months Ended

    September 30,



    ($ in thousands, except per share data)



    2025





    2024





    %

    Change





    2025





    2024





    %

    Change



    Net Sales



    $

    590,284





    $

    546,842







    8

    %



    $

    1,778,228





    $

    1,654,665







    7

    %

    Operating Income



    $

    21,794





    $

    23,949







    (9)

    %



    $

    68,047





    $

    62,785







    8

    %

    Net Income



    $

    10,839





    $

    23,606







    (54)

    %



    $

    41,891





    $

    47,020







    (11)

    %

    Earnings per Diluted Share



    $

    0.47





    $

    1.03







    (54)

    %



    $

    1.83





    $

    2.05







    (11)

    %







































    Adjusted Net Income *



    $

    10,948





    $

    23,661







    (54)

    %



    $

    42,211





    $

    47,713







    (12)

    %

    Adjusted Earnings per

       Diluted Share *



    $

    0.48





    $

    1.03







    (53)

    %



    $

    1.84





    $

    2.08







    (12)

    %

    * See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share.







    Percentage Change in Net Sales

    Net sales in the third quarter of 2025 increased 8% year-over-year.  This increase was primarily driven by higher selling prices that were mainly attributable to the pass-through of higher raw material costs and more favorable product mix.   





    Three Months Ended

    September 30, 2025





    Nine Months Ended

    September 30, 2025



    Volume





    1

    %





    2

    %

    Selling Price & Mix





    6

    %





    6

    %

    Foreign Translation





    1

    %





    (1)

    %

    Total





    8

    %





    7

    %



    Segment Results





    Three Months Ended

    September 30,





    Nine Months Ended

    September 30,



    ($ in thousands)



    2025





    2024





    %

    Change





    2025





    2024





    %

    Change



    Net Sales





































    Surfactants



    $

    422,358





    $

    382,724







    10

    %



    $

    1,264,151





    $

    1,153,339







    10

    %

    Polymers



    $

    143,928





    $

    149,796







    (4)

    %



    $

    452,795





    $

    455,061







    0

    %

    Specialty Products



    $

    23,998





    $

    14,322







    68

    %



    $

    61,282





    $

    46,265







    32

    %

    Total Net Sales



    $

    590,284





    $

    546,842







    8

    %



    $

    1,778,228





    $

    1,654,665







    7

    %







    Three Months Ended

    September 30,





    Nine Months Ended

    September 30,



    ($ in thousands, all amounts pre-tax)



    2025





    2024





    %

    Change





    2025





    2024





    %

    Change



    Operating Income





































    Surfactants



    $

    15,718





    $

    26,303







    (40)

    %



    $

    58,015





    $

    69,445







    (16)

    %

    Polymers



    $

    14,104





    $

    15,248







    (8)

    %



    $

    39,281





    $

    37,227







    6

    %

    Specialty Products



    $

    9,634





    $

    3,727







    158

    %



    $

    20,400





    $

    15,314







    33

    %

    Total Segment

       Operating Income



    $

    39,456





    $

    45,278







    (13)

    %



    $

    117,696





    $

    121,986







    (4)

    %

    Corporate Expenses



    $

    (17,662)





    $

    (21,329)







    (17)

    %



    $

    (49,649)





    $

    (59,201)







    (16)

    %

    Consolidated

       Operating Income



    $

    21,794





    $

    23,949







    (9)

    %



    $

    68,047





    $

    62,785







    8

    %









    Three Months Ended

    September 30,





    Nine Months Ended

    September 30,



    ($ in millions)



    2025





    2024





    %

    Change





    2025





    2024





    %

    Change



    EBITDA



    $

    56.1





    $

    53.0







    6

    %



    $

    164.7





    $

    151.0







    9

    %







































    Adjusted EBITDA





































       Surfactants



    $

    38.0





    $

    44.2







    (14)

    %



    $

    120.9





    $

    122.9







    (2)

    %

       Polymers



    $

    22.4





    $

    23.4







    (4)

    %



    $

    64.0





    $

    61.6







    4

    %

       Specialty Products



    $

    11.1





    $

    5.2







    113

    %



    $

    24.8





    $

    19.8







    25

    %

       Unallocated Corporate



    $

    (15.3)





    $

    (19.7)







    (22)

    %



    $

    (44.6)





    $

    (52.4)







    (15)

    %

    Consolidated Adjusted EBITDA



    $

    56.2





    $

    53.1







    6

    %



    $

    165.1





    $

    151.9







    9

    %



    Consolidated adjusted EBITDA(2) increased $3.1 million, or 6%, in the quarter.  This increase was primarily driven by strong Specialty Products results and the non-recurrence of expenses associated with the external criminal social engineering fraud event in 2024.  Surfactant adjusted EBITDA declined due to a 2% decline in sales volume, lower unit margins and higher costs associated with the start-up of our new alkoxylation site in Pasadena, Texas.

    • Surfactant net sales were $422.4 million for the quarter, a 10% increase versus the prior year. Selling prices were up 11% primarily due to improved product and customer mix and the pass through of higher raw material costs. Sales volume declined 2% year-over-year primarily due to lower demand within the commodity Laundry and Cleaning end markets that was largely offset by double digit growth within the Agricultural and Industrial Cleaning end markets. Foreign currency translation positively impacted net sales by 1%. Surfactant adjusted EBITDA(2) for the quarter decreased $6.2 million, or 14%, versus the prior year. This decrease was primarily due to higher expenses associated with the start-up of our new alkoxylation facility in Pasadena, Texas, a 2% decrease in sales volume and higher oleochemicals raw material costs.



    • Polymer net sales were $143.9 million for the quarter, a 4% decrease versus the prior year. Selling prices decreased 14%, primarily due to the pass-through of lower raw material costs and competitive pressures. Sales volume increased 8% in the quarter. North American Rigid and commodity Phthalic Anhydride sales volume was up double digits year-over-year. Foreign currency translation positively impacted net sales by 2% during the quarter. Polymer adjusted EBITDA(2) decreased $1.0 million, or 4%, versus the prior year primarily due to lower unit margins.



    • Specialty Product net sales were $24.0 million for the quarter, a 68% increase versus the prior year, primarily due to higher sales volume and product mix. Specialty Product adjusted EBITDA(2) increased $5.9 million, or 113%. The increase in adjusted EBITDA(2) was primarily due to order timing fluctuations within the pharmaceutical business.

    Income Taxes

    The Company's effective tax rate was 23.8% in the first nine months of 2025 versus 18.9% in the first nine months of 2024.  This increase was primarily attributable to the recently enacted U.S. Tax Act (H.R.1), lower anticipated R&D tax credits and the expected tax impact of certain cash repatriations to the United States.

    Outlook

    "Looking forward, we remain focused on accelerating our business strategies through enhanced operational excellence, improved product and customer mix and accelerated free cash flow generation.  We believe our Surfactant business will experience continued growth in our key strategic end markets and that Polymer demand will continue improving as we get more market certainty and we execute our innovation and growth plans," said Luis E. Rojo, President and Chief Executive Officer.  "We remain on track to close our asset sale in the Philippines during the fourth quarter. In parallel, we are analyzing opportunities to optimize our footprint and asset base.  Despite the ongoing market and tariff uncertainties, we remain optimistic about delivering full-year Adjusted EBITDA growth and generating positive free cash flow in 2025."

    Notes

    (1) Adjusted net income and adjusted earnings per share are non-GAAP measures which exclude deferred compensation income/expense, certain environmental remediation-related costs as well as other significant and infrequent/non-recurring items. See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share.

    (2) EBITDA and adjusted EBITDA are non-GAAP measures.  See Table VI for calculations and GAAP reconciliations of EBITDA and adjusted EBITDA.

    (3) Free cash flow is a non-GAAP measure and reflects cash generated from operations minus capital expenditures.  Cash generated from operations was $69.8 million during the third quarter of 2025 and capital expenditures were $29.6 million. 

    Conference Call

    Stepan Company will host a conference call to discuss its third quarter results at 9:00 a.m. ET (8:00 a.m. CT) on October 29, 2025. The call can be accessed by phone and webcast. To access the call by phone, please click on this Registration Link, complete the form and you will be provided with dial in details and a PIN.  To avoid delays, we encourage participants to dial into the conference call ten minutes ahead of the scheduled start time.  The webcast can be accessed through the Investors/Conference Calls page at www.stepan.com. A webcast replay of the conference call will be available at the same location shortly after the call.

    Supporting Slides

    Slides supporting this press release will be made available at www.stepan.com through the Investors/Presentations page at approximately the same time as this press release is issued.

    Corporate Profile

    Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries. Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning and disinfection compounds and in agricultural and oilfield solutions. The Company is also a leading supplier of polyurethane polyols used in the expanding thermal insulation market, and CASE (Coatings, Adhesives, Sealants, and Elastomers) industries.

    Headquartered in Northbrook, Illinois, Stepan utilizes a network of modern production facilities located in North and South America, Europe and Asia. 

    The Company's common stock is traded on the New York Stock Exchange (NYSE) under the symbol SCL. For more information about Stepan Company please visit the Company online at www.stepan.com

    More information about Stepan's sustainability program can be found on the Sustainability page at www.stepan.com 

    Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about Stepan Company's plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, Stepan Company's actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "guidance," "predict," "potential," "continue," "likely," "will," "would," "should," "illustrative" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by Stepan Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements.

    There are a number of risks, uncertainties and other important factors, many of which are beyond Stepan Company's control, that could cause actual results to differ materially from the forward-looking statements contained in this news release. Such risks, uncertainties and other important factors include, among other factors, the risks, uncertainties and factors described in Stepan Company's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports, and include (but are not limited to) risks and uncertainties related to  accidents, unplanned production shutdowns or disruptions in manufacturing facilities; reduced demand due to customer product reformulations or new technologies; our inability to successfully develop or introduce new products; compliance with laws; our ability to identify suitable acquisition candidates and successfully complete and integrate acquisitions; global competition; volatility of raw material and energy costs and supply; disruptions in transportation or significant changes in transportation costs; downturns in certain industries and general economic downturns; international business risks, including currency exchange rate fluctuations, changes in global trade policies, including tariffs; legal restrictions and taxes; unfavorable resolution of litigation against us; maintaining and protecting intellectual property rights; our ability to access capital markets; global political, military, security or other instability; costs related to expansion or other capital projects; interruption or breaches of information technology systems; our ability to retain executive management and key personnel; and our debt covenants.

    These forward-looking statements are made only as of the date hereof, and Stepan Company undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

    * * * * *

    Tables follow

    Table I

    STEPAN COMPANY

    For the Three and Nine Months Ended September 30, 2025 and 2024

    (Unaudited – in 000's, except per share data)







    Three Months Ended

    September 30,





    Nine Months Ended

    September 30,







    2025





    2024





    2025





    2024



    Net Sales



    $

    590,284





    $

    546,842





    $

    1,778,228





    $

    1,654,665



    Cost of Sales





    519,261







    471,157







    1,559,857







    1,439,147



    Gross Profit





    71,023







    75,685







    218,371







    215,518



    Operating Expenses:

























    Selling





    11,299







    11,394







    38,064







    34,610



    Administrative





    22,864







    26,254







    67,079







    73,513



    Research, Development and Technical Services





    14,225







    13,532







    43,575







    41,881



    Deferred Compensation Expense





    841







    556







    1,606







    2,729









    49,229







    51,736







    150,324







    152,733





























    Operating Income





    21,794







    23,949







    68,047







    62,785





























    Other Income (Expense):

























    Interest, Net





    (6,815)







    (3,621)







    (16,426)







    (9,353)



    Other, Net





    1,536







    989







    3,344







    4,551









    (5,279)







    (2,632)







    (13,082)







    (4,802)





























    Income Before Provision for Income Taxes





    16,515







    21,317







    54,965







    57,983



    Provision for Income Taxes





    5,676







    (2,289)







    13,074







    10,963



    Net Income





    10,839







    23,606







    41,891







    47,020



    Net Income Per Common Share

























    Basic



    $

    0.47





    $

    1.03





    $

    1.83





    $

    2.06



    Diluted



    $

    0.47





    $

    1.03





    $

    1.83





    $

    2.05



    Shares Used to Compute Net Income Per

       Common Share

























    Basic





    22,875







    22,836







    22,869







    22,829



    Diluted





    22,893







    22,923







    22,888







    22,936



     

    Table II



    Reconciliation of Non-GAAP Net Income and Earnings per Diluted Share* 







    Three Months Ended

    September 30,





    Nine Months Ended

    September 30,



    ($ in thousands, except per share amounts)



    2025





    EPS





    2024





    EPS





    2025





    EPS





    2024





    EPS



    Net Income Reported



    $

    10,839





    $

    0.47





    $

    23,606





    $

    1.03





    $

    41,891





    $

    1.83





    $

    47,020





    $

    2.05





















































    Deferred Compensation (Income)



    $

    (149)





    $

    -





    $

    (350)





    $

    (0.02)





    $

    (549)





    $

    (0.02)





    $

    (1,043)





    $

    (0.05)



    Environmental Remediation

        Expense



    $

    258





    $

    0.01





    $

    405





    $

    0.02





    $

    869





    $

    0.03





    $

    1,736





    $

    0.08



    Adjusted Net Income



    $

    10,948





    $

    0.48





    $

    23,661





    $

    1.03





    $

    42,211





    $

    1.84





    $

    47,713





    $

    2.08





    * All amounts in this table are presented after-tax



    The Company believes that certain non-GAAP measures, in conjunction with comparable GAAP measures, are useful for evaluating the Company's operating performance and financial condition.  The Company uses this non-GAAP information as an indicator of business performance and evaluates management's effectiveness with specific reference to these indicators.  Management believes that these non-GAAP financial measures provide useful supplemental information because they exclude non-operational items that affect comparability between years.  These measures should be considered in addition to, not as substitutes for or superior to, measures of financial performance prepared in accordance with GAAP and may differ from similarly titled measures presented by other companies.  The Company's Annual Report on Form 10-K for the year ended December 31, 2024 contains additional information regarding the use of non-GAAP financial measures.

    Summary of Third Quarter 2025 Adjusted Net Income Items

    Adjusted net income excludes non-operational deferred compensation income/expense, certain environmental remediation costs and other significant and infrequent or non-recurring items.

    • Deferred Compensation: The third quarter of 2025 reported net income includes $0.1 million of after-tax income versus $0.4 million of after-tax income in the prior year.



    • Environmental Remediation: The third quarter of 2025 reported net income includes $0.3 million of after-tax expense versus $0.4 million of after-tax expense in the prior year.

    Table III



    Reconciliation of Pre-Tax to After-Tax Adjustments



    Management uses the non-GAAP adjusted net income metric to evaluate the Company's operating performance.  Management excludes the items listed in the table below because they are non-operational items.  The cumulative tax effect was calculated using the statutory tax rates for the jurisdictions in which the transactions occurred.







    Three Months Ended

    September 30,





    Nine Months Ended

    September 30,



    ($ in thousands, except per share amounts)



    2025





    EPS





    2024





    EPS





    2025





    EPS





    2024





    EPS



    Pre-Tax Adjustments

















































    Deferred Compensation (Income)



    $

    (198)











    $

    (466)











    $

    (732)











    $

    (1,390)









    Environmental Remediation Expense



    $

    344











    $

    541











    $

    1,158











    $

    2,315









       Total Pre-Tax Adjustments



    $

    146











    $

    75











    $

    426











    $

    925



























































    Cumulative Tax Effect on Adjustments



    $

    (37)











    $

    (20)











    $

    (106)











    $

    (232)



























































    After-Tax Adjustments



    $

    109





    $

    0.01





    $

    55





    $

    -





    $

    320





    $

    0.01





    $

    693





    $

    0.03



     

    Table IV



    Deferred Compensation Plans



    The full effect of the deferred compensation plans on quarterly pre-tax income was $0.2 million of income versus $0.5 million of income in the prior year.  The quarter-end market prices of Company stock and the impact of deferred compensation on specific income statement line items is summarized below:







    2025





    2024







    9/30





    6/30





    3/31





    12/31





    9/30





    6/30





    3/31



    Stepan Company



    $

    47.70





    $

    54.58





    $

    55.04





    $

    64.70





    $

    77.25





    $

    83.96





    $

    90.04



     





    Three Months Ended

    September 30,





    Nine Months Ended

    September 30,



    ($ in thousands)



    2025





    2024





    2025





    2024



    Deferred Compensation

























    Operating Income (Expense)



    $

    (841)





    $

    (556)





    $

    (1,606)





    $

    (2,729)



    Other, net – Mutual Fund Gain (Loss)





    1,039







    1,022







    2,338







    4,119



    Total Pre-Tax



    $

    198





    $

    466





    $

    732





    $

    1,390



    Total After-Tax



    $

    149





    $

    350





    $

    549





    $

    1,043





    Effects of Foreign Currency Translation

    The Company's foreign subsidiaries transact business and report financial results in their respective local currencies. These results are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period.  The table below presents the impact that foreign currency translation had on select income statement line items. 

    ($ in millions)



    Three Months Ended

    September 30,





    Change





    Change

    Due to

    Foreign

    Currency

    Translation





    Nine Months Ended

    September 30,





    Change





    Change

    Due to

    Foreign

    Currency

    Translation







    2025





    2024

















    2025





    2024















    Net Sales



    $

    590.3





    $

    546.8





    $

    43.5





    $

    8.6





    $

    1,778.2





    $

    1,654.7





    $

    123.5





    $

    (11.6)



    Gross Profit





    71.0







    75.7





    $

    (4.7)







    1.0







    218.4







    215.5





    $

    2.9







    (1.9)



    Operating Income





    21.8







    23.9





    $

    (2.1)







    0.5







    68.0







    62.8





    $

    5.2







    (1.5)



    Pretax Income





    16.5







    21.3





    $

    (4.8)







    0.5







    55.0







    58.0





    $

    (3.0)







    (1.6)





































































    Corporate Expenses





    Three Months Ended

    September 30,





    Nine Months Ended

    September 30,



    ($ in thousands)



    2025





    2024





    %

    Change





    2025





    2024





    %

    Change



    Total Corporate Expenses



    $

    17,662





    $

    21,329







    (17)

    %



    $

    49,649





    $

    59,201







    (16)

    %

    Less:





































       Deferred Compensation Expense



    $

    841





    $

    556







    51

    %



    $

    1,606





    $

    2,729







    (41)

    %

       Environmental Remediation

          Expense



    $

    344





    $

    541







    (36)

    %



    $

    1,158





    $

    2,315







    (50)

    %

    Adjusted Corporate Expenses



    $

    16,477





    $

    20,232







    (19)

    %



    $

    46,885





    $

    54,157







    (13)

    %



    Adjusted Corporate expenses decreased $3.8 million, or 19% for the quarter.  This decrease was primarily due to the non-recurrence of expenses associated with a criminal social engineering scheme in 2024.

    Table V



    Stepan Company

    Consolidated Balance Sheets

    September 30, 2025 and December 31, 2024







    September 30,

    2025





    December 31,

    2024



    ASSETS













    Current Assets



    $

    920,604





    $

    810,429



    Property, Plant & Equipment, Net





    1,213,862







    1,198,454



    Other Assets





    297,818







    295,765



    Total Assets



    $

    2,432,284





    $

    2,304,648



    LIABILITIES AND STOCKHOLDERS' EQUITY













    Current Liabilities



    $

    713,923





    $

    669,034



    Deferred Income Taxes





    10,294







    9,612



    Long-term Debt





    357,107







    332,632



    Other Non-current Liabilities





    104,188







    123,436



    Total Stepan Company Stockholders' Equity





    1,246,772







    1,169,934



    Total Liabilities and Stockholders' Equity



    $

    2,432,284





    $

    2,304,648







    Selected Balance Sheet Information 

    The Company's total debt decreased by $2.5 million and cash increased by $29.6 million versus June 30, 2025.  The Company's net debt level decreased $32.1 million versus June 30, 2025 and the net debt ratio was 30% versus 31% in the prior quarter (Net Debt and Net Debt Ratio are non-GAAP measures, reconciliations of which are shown in the table below).  Management uses the non-GAAP net debt metric to show a more complete picture of the Company's overall liquidity, financial flexibility and leverage level. 

    ($ in millions)



    September 30,

    2025





    June 30,

    2025





    March 31,

    2025





    December 31,

    2024



    Net Debt

























    Total Debt



    $

    655.5





    $

    658.0





    $

    659.3





    $

    625.4



    Cash





    118.5







    88.9







    107.5







    99.7



    Net Debt



    $

    537.0





    $

    569.1





    $

    551.8





    $

    525.7



    Equity





    1,246.8







    1,241.7







    1,200.5







    1,169.9



    Net Debt + Equity



    $

    1,783.8





    $

    1,810.8





    $

    1,752.3





    $

    1,695.6



    Net Debt / (Net Debt + Equity)





    30

    %





    31

    %





    31

    %





    31

    %



    The major working capital components were:

    ($ in millions)



    September 30,

    2025





    June 30,

    2025





    March 31,

    2025





    December 31,

    2024



    Net Receivables



    $

    436.1





    $

    442.2





    $

    436.5





    $

    388.0



    Inventories





    324.3







    329.5







    309.3







    288.7



    Accounts Payable





    (289.4)







    (281.8)







    (298.1)







    (258.8)







    $

    471.0





    $

    489.9





    $

    447.7





    $

    417.9



     

    Table VI



    Reconciliations of Non-GAAP EBITDA and Adjusted EBITDA



    Management uses the non-GAAP EBITDA and adjusted EBITDA metrics to evaluate the Company's operating performance.  Management excludes the items listed in the table below because they are non-operational items.  Refer to the Income Statement on Table I for a bridge between Operating Income and Net Income.







    Three Months Ended

    September 30, 2025



































    ($ in millions)



    Surfactants





    Polymers





    Specialty

    Products





    Unallocated

    Corporate





    Consolidated



    Operating Income



    $

    15.7





    $

    14.1





    $

    9.6





    $

    (17.7)





    $

    21.8



       Depreciation and Amortization



    $

    22.3





    $

    8.3





    $

    1.5





    $

    0.7





    $

    32.8



       Other, Net Income



    $

    -





    $

    -





    $

    -





    $

    1.5





    $

    1.5



    EBITDA



























    $

    56.1



       Deferred Compensation



    $

    -





    $

    -





    $

    -





    $

    (0.2)





    $

    (0.2)



       Environmental Remediation



    $

    -





    $

    -





    $

    -





    $

    0.3





    $

    0.3



    Adjusted EBITDA



    $

    38.0





    $

    22.4





    $

    11.1





    $

    (15.3)





    $

    56.2







































    Three Months Ended

    September 30, 2024



































    ($ in millions)



    Surfactants





    Polymers





    Specialty

    Products





    Unallocated

    Corporate





    Consolidated



    Operating Income



    $

    26.3





    $

    15.2





    $

    3.7





    $

    (21.3)





    $

    23.9



       Depreciation and Amortization



    $

    17.9





    $

    8.2





    $

    1.5





    $

    0.5





    $

    28.1



       Other, Net Income



    $

    -





    $

    -





    $

    -





    $

    1.0





    $

    1.0



    EBITDA



























    $

    53.0



       Deferred Compensation



    $

    -





    $

    -





    $

    -





    $

    (0.4)





    $

    (0.4)



       Environmental Remediation



    $

    -





    $

    -





    $

    -





    $

    0.5





    $

    0.5



    Adjusted EBITDA



    $

    44.2





    $

    23.4





    $

    5.2





    $

    (19.7)





    $

    53.1











    Nine Months Ended

    September 30, 2025



































    ($ in millions)



    Surfactants





    Polymers





    Specialty

    Products





    Unallocated

    Corporate





    Consolidated



    Operating Income



    $

    58.0





    $

    39.3





    $

    20.4





    $

    (49.6)





    $

    68.1



       Depreciation and Amortization



    $

    62.9





    $

    24.7





    $

    4.4





    $

    1.3





    $

    93.3



       Other, Net Income



    $

    -





    $

    -





    $

    -





    $

    3.3





    $

    3.3



    EBITDA



























    $

    164.7



       Deferred Compensation



    $

    -





    $

    -





    $

    -





    $

    (0.7)





    $

    (0.7)



       Environmental Remediation



    $

    -





    $

    -





    $

    -





    $

    1.1





    $

    1.1



    Adjusted EBITDA



    $

    120.9





    $

    64.0





    $

    24.8





    $

    (44.6)





    $

    165.1







































    Nine Months Ended

    September 30, 2024



































    ($ in millions)



    Surfactants





    Polymers





    Specialty

    Products





    Unallocated

    Corporate





    Consolidated



    Operating Income



    $

    69.4





    $

    37.2





    $

    15.3





    $

    (59.2)





    $

    62.7



       Depreciation and Amortization



    $

    53.5





    $

    24.4





    $

    4.5





    $

    1.3





    $

    83.7



       Other, Net Income



    $

    -





    $

    -





    $

    -





    $

    4.6





    $

    4.6



    EBITDA



























    $

    151.0



       Deferred Compensation



    $

    -





    $

    -





    $

    -





    $

    (1.4)





    $

    (1.4)



       Environmental Remediation



    $

    -





    $

    -





    $

    -





    $

    2.3





    $

    2.3



    Adjusted EBITDA



    $

    122.9





    $

    61.6





    $

    19.8





    $

    (52.4)





    $

    151.9



       

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/stepan-reports-third-quarter-2025-results-302597881.html

    SOURCE Stepan Company

    Get the next $SCL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SCL

    DatePrice TargetRatingAnalyst
    10/19/2023$89.00Neutral → Buy
    CL King
    3/11/2022$9.00 → $8.00Outperform
    RBC Capital
    12/20/2021$8.50 → $9.00Outperform
    RBC Capital
    More analyst ratings

    $SCL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by VP & CHRO Barry Andrea Jean

    4 - STEPAN CO (0000094049) (Issuer)

    11/10/25 9:50:43 PM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 3 filed by new insider Barry Andrea Jean

    3 - STEPAN CO (0000094049) (Issuer)

    10/7/25 2:58:07 PM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 4 filed by VP GC & Secretary Lisle Shawn G

    4 - STEPAN CO (0000094049) (Issuer)

    8/27/25 5:21:53 PM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    $SCL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Stepan Company Completes Sale of Philippine Assets, Advancing Strategic Focus on Core Growth

    NORTHBROOK, Ill., Nov. 20, 2025 /PRNewswire/ -- Stepan Company (NYSE: SCL) today announced the successful closing, on November 14, 2025, of the sale of its subsidiary, Stepan Philippines Quaternaries, Inc. (SPQI), manufacturing assets located in Bauan, Batangas, Philippines to Masurf, Inc., a subsidiary of Musim Mas Holdings Pte. Ltd. This transaction fulfills SPQI's previously announced Asset Transfer Agreement, dated May 27, 2025, and underscores Stepan's commitment to its strategic priorities. As part of closing, SPQI entered into a tolling agreement with Masurf for the continued service of SPQI customers in Southeast Asia. Terms of the transaction were not disclosed.

    11/20/25 4:01:00 PM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    Stepan Reports Third Quarter 2025 Results

    NORTHBROOK, Ill., Oct. 29, 2025 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: Third Quarter 2025 Highlights Reported net income was $10.8 million, down 54% versus the prior year. Adjusted net income(1) was $10.9 million, down 54% versus the prior year, largely due to a higher effective tax rate and higher interest expense.EBITDA(2) was $56.1 million and Adjusted EBITDA(2) was $56.2 million, both up 6% respectively, year-over-year.Global sales volume was up 1% year-over-year.Cash from Operations was $69.8 million during the quarter. Free cash flow(3) for the quarter

    10/29/25 7:00:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    Stepan Increases Quarterly Cash Dividend, Marking the 58th Consecutive Year of Increases

    NORTHBROOK, Ill., Oct. 29, 2025 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: The Board of Directors of Stepan Company has approved an increase of $0.01 per share, or 2.6%, on the quarterly cash dividend on the Company's common stock. The dividend of $0.395 per share is payable on December 15, 2025, to common stockholders of record on November 28, 2025. The increase marks the 58th consecutive year in which the quarterly dividend on the Company's common stock has increased. Corporate ProfileStepan Company is a major manufacturer of specialty and intermediate chemica

    10/29/25 7:00:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    $SCL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Stepan Company upgraded by CL King with a new price target

    CL King upgraded Stepan Company from Neutral to Buy and set a new price target of $89.00

    10/19/23 9:02:32 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    RBC Capital reiterated coverage on Shawcor with a new price target

    RBC Capital reiterated coverage of Shawcor with a rating of Outperform and set a new price target of $8.00 from $9.00 previously

    3/11/22 7:14:07 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    RBC Capital reiterated coverage on Shawcor with a new price target

    RBC Capital reiterated coverage of Shawcor with a rating of Outperform and set a new price target of $9.00 from $8.50 previously

    12/20/21 6:55:29 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    $SCL
    Leadership Updates

    Live Leadership Updates

    View All

    Stepan Announces Appointment of New Vice President and Chief Financial Officer

    NORTHBROOK, Ill., July 14, 2025 /PRNewswire/ -- Stepan Company (NYSE:SCL) announced today the appointment of Ruben Velasquez as Vice President and Chief Financial Officer of Stepan, effective as of July 15, 2025. Mr. Velasquez will succeed Samuel Hinrichsen who, as previously reported, is presently serving as Vice President and Interim Chief Financial Officer. Mr. Hinrichsen will continue in his role as Vice President of Finance. Mr. Velasquez most recently served as Vice President Global Finance Transformation at 3M Company. Prior to that, Mr. Velasquez held several senior fi

    7/14/25 7:00:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    Stepan Company Announces Appointment of New Director

    NORTHBROOK, Ill., June 9, 2025 /PRNewswire/ -- Stepan Company (NYSE: SCL) announced today the appointment of Corning Painter as a Director of Stepan, effective immediately. Mr. Painter currently serves as Chief Executive Officer of Orion S.A., a global chemical manufacturer, a role he has held since September of 2018. Prior to joining Orion, Mr. Painter was an Executive Vice President for Industrial Gases at Air Products and Chemicals, an industrial gas company, which Mr. Painter joined in 1984. Mr. Painter is a Certified Professional Engineer and holds a chemical engineering

    6/9/25 7:00:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    Stepan Promotes Luis E. Rojo to President and Chief Executive Officer

    NORTHBROOK, Ill., Oct. 30, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today announced the appointment of Luis E. Rojo as President and Chief Executive Officer and as a member of the Board of Directors, effective immediately. After a 31-year Stepan career, Scott R. Behrens is departing the Company to pursue other opportunities. "We thank Scott for his leadership and his many contributions to the growth and diversification of Stepan over his career with the Company. During his various roles in R&D, sales and marketing, and leadership, he helped diversify our market presence,

    10/30/24 6:55:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    $SCL
    Financials

    Live finance-specific insights

    View All

    Stepan Reports Third Quarter 2025 Results

    NORTHBROOK, Ill., Oct. 29, 2025 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: Third Quarter 2025 Highlights Reported net income was $10.8 million, down 54% versus the prior year. Adjusted net income(1) was $10.9 million, down 54% versus the prior year, largely due to a higher effective tax rate and higher interest expense.EBITDA(2) was $56.1 million and Adjusted EBITDA(2) was $56.2 million, both up 6% respectively, year-over-year.Global sales volume was up 1% year-over-year.Cash from Operations was $69.8 million during the quarter. Free cash flow(3) for the quarter

    10/29/25 7:00:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    Stepan Increases Quarterly Cash Dividend, Marking the 58th Consecutive Year of Increases

    NORTHBROOK, Ill., Oct. 29, 2025 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: The Board of Directors of Stepan Company has approved an increase of $0.01 per share, or 2.6%, on the quarterly cash dividend on the Company's common stock. The dividend of $0.395 per share is payable on December 15, 2025, to common stockholders of record on November 28, 2025. The increase marks the 58th consecutive year in which the quarterly dividend on the Company's common stock has increased. Corporate ProfileStepan Company is a major manufacturer of specialty and intermediate chemica

    10/29/25 7:00:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    Stepan to Announce Third Quarter 2025 Results on October 29, 2025

    NORTHBROOK, Ill., Oct. 8, 2025 /PRNewswire/ -- Stepan Company (NYSE:SCL) will issue its third quarter 2025 earnings results on Wednesday, October 29, 2025 at approximately 7:00 a.m. ET (6:00 a.m. CT). Supporting slides will be posted at approximately the same time on the Investors/Presentations page at www.stepan.com. The Company will hold a conference call to discuss and answer questions about its financial and operational performance on the same day at 9:00 a.m. ET (8:00 a.m. CT). The call will be hosted by Luis E. Rojo, President and Chief Executive Officer, and Ruben D. Ve

    10/8/25 7:00:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    $SCL
    SEC Filings

    View All

    SEC Form 8-K filed by Stepan Company

    8-K - STEPAN CO (0000094049) (Filer)

    11/28/25 4:10:36 PM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 10-Q filed by Stepan Company

    10-Q - STEPAN CO (0000094049) (Filer)

    11/5/25 10:22:15 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    Stepan Company filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - STEPAN CO (0000094049) (Filer)

    10/29/25 7:00:28 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    $SCL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lewis Susan bought $31,765 worth of shares (500 units at $63.53), increasing direct ownership by 36% to 1,896 units (SEC Form 4)

    4 - STEPAN CO (0000094049) (Issuer)

    2/27/25 8:57:39 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    VP GC & Secretary Kabbes David bought $75,388 worth of shares (1,056 units at $71.39) (SEC Form 4)

    4 - STEPAN CO (0000094049) (Issuer)

    8/15/24 1:19:55 PM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    $SCL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Stepan Company

    SC 13G - STEPAN CO (0000094049) (Subject)

    2/9/24 9:59:18 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13G/A filed by Stepan Company (Amendment)

    SC 13G/A - STEPAN CO (0000094049) (Subject)

    1/24/24 12:33:12 PM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13G/A filed by Stepan Company (Amendment)

    SC 13G/A - STEPAN CO (0000094049) (Subject)

    1/22/24 3:52:11 PM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary